Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655 [PMID: 38948099 DOI: 10.4252/wjsc.v16.i6.641]
Corresponding Author of This Article
Serdar Kabatas, MD, Full Professor, Department of Neurosurgery, University of Health Sciences Turkey, Gaziosmanpaşa Training and Research Hospital, Karayolları Mahallesi, Osmanbey Caddesi 616. Sokak No. 10, Gaziosmanpaşa, Istanbul 34360, Türkiye. kabatasserdar@hotmail.com
Research Domain of This Article
Neurosciences
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Stem Cells. Jun 26, 2024; 16(6): 641-655 Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Table 1 Study group characteristics
Characteristics
n
%
Age (yr)
21
1
16.7
22
1
16.7
25
2
33.3
26
1
16.7
27
1
16.7
Sex
Female
2
33.3
Male
4
66.7
Cause of spinal cord injury
Traffic accident
6
100.0
Comorbidity
None
6
100.0
Treatments before transplantation
Non-surgical
2
33.3
Decompressive craniectomy
1
16.7
Acute subdural hematoma evacuation and ventriculoperitoneal shunt
1
16.7
Decompressive craniectomy and ventriculoperitoneal shunt
1
16.7
Ventriculoperitoneal shunt
1
16.7
Duration between spinal cord injury and first transplantation
6 months
1
16.7
18 months
1
16.7
22 months
1
16.7
24 months
2
33.3
48 months
1
16.7
Table 2 Administration schedule
Date
Route
WJ-MSCs
Round 1
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Round 2 (2nd wk)
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Round 3 (1st month)
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Round 4 (2nd month)
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Round 5 (3rd month)
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Round 6 (4th month)
I.t.
1 × 106/kg (3 mL in total)
I.v.
1 × 106/kg (30 mL in total)
I.m.
1 × 106/kg (20 mL in total)
Table 3 Friedman test results of the changes observed in the Functional Independence Measure Motor Score values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
13.17
0.41
2.67
14.310
5
0.014
Postoperative 1st wk
6
13.17
0.41
2.67
Postoperative 1st month
6
13.33
0.82
2.92
Postoperative 2nd month
6
14.17
1.60
4.08
Postoperative 4th month
6
14.33
1.97
4.33
Postoperative 1st yr
6
14.33
1.97
4.33
Table 4 Functional Independence Measure Motor Score values of each patient
FIM Scale, Motor Score: Self-care/Sphincter Control/Transfers/Locomotion
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
13
13
13
15
15
15
Patient 2
14
14
15
17
18
18
Patient 3
13
13
13
13
13
13
Patient 4
13
13
13
14
14
14
Patient 5
13
13
13
13
13
13
Patient 6
13
13
13
13
13
13
Table 5 Friedman test results of the changes observed in the Functional Independence Measure Cognitive Score values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
5.67
1.63
1.58
26.160
5
0.000
Postoperative 1st wk
6
6.50
1.76
2.08
Postoperative 1st month
6
7.67
2.42
2.92
Postoperative 2nd month
6
8.83
3.49
3.75
Postoperative 6th month
6
11.00
4.43
4.92
Postoperative 1st yr
6
11.83
3.97
5.75
Table 6 Functional Independence Measure Cognitive Score values of each patient
FIM Scale, Cognitive Score: Communication/Social Cognition (TS:35)
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
5
5
8
9
11
11
Patient 2
9
9
12
15
17
18
Patient 3
5
5
6
6
8
8
Patient 4
5
7
7
9
15
15
Patient 5
5
8
8
9
10
11
Patient 6
5
5
5
5
5
8
Table 7 Friedman test results of the changes observed in the Modified Ashworth Score right values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
19.83
4.58
5.58
28.641
5
0.000
Postoperative 1st wk
6
19.50
4.46
5.33
Postoperative 1st month
6
17.33
4.68
4.00
Postoperative 2nd month
6
16.17
5.35
2.83
Postoperative 4th month
6
15.17
4.99
1.83
Postoperative 1st yr
6
13.83
4.83
1.42
Table 8 Modified Ashworth Score right values of each patient
Modified Ashworth Score (right)
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
19
19
16
14
12
12
Patient 2
20
20
16
15
14
14
Patient 3
20
20
18
17
16
11
Patient 4
26
26
24
24
22
22
Patient 5
12
12
10
8
8
8
Patient 6
22
20
20
19
19
16
Table 9 Friedman test results of the changes observed in the Modified Ashworth Score left values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
18.83
5.04
5.58
28.462
5
0.000
Postoperative 1st wk
6
18.50
4.85
5.25
Postoperative 1st month
6
16.33
4.68
3.83
Postoperative 2nd month
6
15.83
5.04
3.25
Postoperative 4th month
6
14.33
4.18
1.83
Postoperative 1st yr
6
13.00
4.60
1.25
Table 10 Modified Ashworth Score left values of each patient
Modified Ashworth Score (left)
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
19
19
16
16
14
12
Patient 2
20
20
15
14
13
13
Patient 3
20
20
18
17
16
11
Patient 4
23
23
21
21
19
19
Patient 5
9
9
8
7
7
6
Patient 6
22
20
20
20
17
17
Table 11 Friedman test results of the changes observed in the Medical Research Council muscle strength scale right values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
3.33
1.86
2.58
13.214
5
0.021
Postoperative 1st wk
6
3.33
1.86
2.58
Postoperative 1st month
6
3.67
1.51
3.33
Postoperative 2nd month
6
4.00
1.10
4.00
Postoperative 4th month
6
4.17
0.98
4.25
Postoperative 1st yr
6
4.17
0.98
4.25
Table 12 Medical Research Council muscle strength scale right values of each patient
MRC muscle strength scale (right)
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
2
2
2
3
3
3
Patient 2
2
2
3
3
3
3
Patient 3
5
5
5
5
5
5
Patient 4
1
1
2
3
4
4
Patient 5
5
5
5
5
5
5
Patient 6
5
5
5
5
5
5
Table 13 Friedman test results of the changes observed in the Medical Research Council muscle strength scale left values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
3.33
1.86
2.58
13.506
5
0.019
Postoperative 1st wk
6
3.33
1.86
2.58
Postoperative 1st month
6
3.67
1.51
3.25
Postoperative 2nd month
6
4.00
1.10
4.08
Postoperative 4th month
6
4.00
1.10
4.08
Postoperative 1st yr
6
4.17
0.98
4.42
Table 14 Medical Research Council muscle strength scale left values of each patient
MRC muscle strength scale (left)
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
2
2
2
3
3
3
Patient 2
2
2
3
3
3
4
Patient 3
5
5
5
5
5
5
Patient 4
1
1
2
3
3
3
Patient 5
5
5
5
5
5
5
Patient 6
5
5
5
5
5
5
Table 15 Friedman test results of the changes observed in the Karnofsky performance scale values of the patients before and after the intervention
n
Mean
SD
Mean rank
χ2
df
P value
Preoperative
6
15.00
5.48
1.92
27.557
5
0.000
Postoperative 1st wk
6
15.00
5.48
1.92
Postoperative 1st month
6
21.67
11.69
2.92
Postoperative 2nd month
6
23.33
12.11
3.25
Postoperative 4th month
6
33.33
12.11
5.33
Postoperative 1st yr
6
36.67
15.06
5.67
Table 16 Karnofsky performance scale values of each patient
Karnofsky performance scale
Pre-test
Post-test (1st wk)
Post-test (1st month)
Post-test (2nd month)
Post-test (4th month)
Post-test (12th month)
Patient 1
10
10
20
20
30
30
Patient 2
20
20
40
40
50
50
Patient 3
20
20
20
30
40
50
Patient 4
20
20
30
30
40
50
Patient 5
10
10
10
10
20
20
Patient 6
10
10
10
10
20
20
Citation: Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655